DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $795,000 | +25.0% | 9,296 | +13.8% | 0.05% | +71.4% |
Q4 2016 | $636,000 | -0.6% | 8,166 | 0.0% | 0.03% | -3.4% |
Q3 2016 | $640,000 | -22.4% | 8,166 | 0.0% | 0.03% | -19.4% |
Q2 2016 | $825,000 | +8.7% | 8,166 | +2.1% | 0.04% | +16.1% |
Q1 2016 | $759,000 | -53.6% | 7,996 | -54.6% | 0.03% | -52.3% |
Q4 2015 | $1,637,000 | +9.0% | 17,624 | 0.0% | 0.06% | +10.2% |
Q3 2015 | $1,502,000 | -0.4% | 17,624 | 0.0% | 0.06% | +31.1% |
Q2 2015 | $1,508,000 | +0.8% | 17,624 | 0.0% | 0.04% | +4.7% |
Q1 2015 | $1,496,000 | +5.4% | 17,624 | +6.4% | 0.04% | +7.5% |
Q4 2014 | $1,420,000 | +12.8% | 16,564 | 0.0% | 0.04% | +21.2% |
Q3 2014 | $1,259,000 | -3.5% | 16,564 | 0.0% | 0.03% | +3.1% |
Q2 2014 | $1,304,000 | +5.0% | 16,564 | 0.0% | 0.03% | +18.5% |
Q1 2014 | $1,242,000 | -2.9% | 16,564 | 0.0% | 0.03% | 0.0% |
Q4 2013 | $1,279,000 | +10.6% | 16,564 | -0.7% | 0.03% | +12.5% |
Q3 2013 | $1,156,000 | +9.5% | 16,677 | 0.0% | 0.02% | +14.3% |
Q2 2013 | $1,056,000 | – | 16,677 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |